PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1401789
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1401789
Artificial Urinary Sphincter Market size was valued at USD 500 Million in 2022, expanding at a CAGR of 8.1% from 2023 to 2030.
An artificial urinary sphincter is a device that is implanted, usually in men, to treat moderate to severe stress urine incontinence. The natural urinary sphincter, which limits the flow of urine out of the bladder, is meant to be supplemented by the artificial urinary sphincter (AUS).
Artificial Urinary Sphincter Market- Market Dynamics
Increasing prevalence of urge, stress Urinary Incontinence (UI) to propel market demand
Urge-related stress urinary incontinence (UI), rising healthcare costs in developing nations, and an increase in clinical studies are the main reasons propelling the market's growth. Additionally, the AUS is crucial to the treatment of patients with urine incontinence. It is thought to be a safe and dependable therapeutic choice for men with UI, especially those who are having sphincter dysfunction or are having prostate surgery. Prostate procedures are on the rise primarily due to the increasing incidence of benign prostatic hyperplasia (BPH), prostate cancer, and other urological illnesses. Urgent urine incontinence (UUI) and stress are two of the most dangerous side effects after prostate cancer surgery. The most severe UUI cases have been treated with the AUS, which is regarded as the gold standard. Statistics from Cleveland Clinic indicate that around 90,000 prostatectomies performed in the U.S.
Artificial Urinary Sphincter Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.1% over the forecast period (2023-2030)
Based on Brand segmentation, AMS800 was predicted to show maximum market share in the year 2022, owing to growing need for effective AUS devices.
Based on End-User segmentation, male segment was the leading Brand in 2022, mainly due to high prevalence of incontinence in the male.
Based on Application segmentation, hospitals was the leading Brand in 2022, mainly due to growing adoption of AUS in hospitals.
On the basis of region, North America was the leading revenue generator in 2022, owing to high healthcare expenditure and improved healthcare infrastructure.
The Global Artificial Urinary Sphincter Market is segmented on the basis of Brand, End-User, Application, and Region.
The market is divided into two categories based on Brand: AMS800 and others. The AMS800 segment dominates the market. This is due to AMS800 effectiveness and safe surgical options in SUI treatment.
The market is divided into two categories based on End-User: male and female. The male segment dominates the market and is likely to maintain its dominance during the forecast period. This is partly due to the growing prevalence of prostate surgery, trauma, or nerve injury.
The market is divided into three categories based on Application: hospitals, ambulatory surgical centers, and others. The hospitals dominate the market and is likely to maintain its dominance during the forecast period. This is due to high demand for surgical, urinal disease patient treatment in hospitals is boosting the market growth.
Artificial Urinary Sphincter Market- Geographical Insights
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.
North America region dominated the global Artificial Urinary Sphincter Market. AUS market is highly competitive in nature. The significant R&D expenditures, and mergers and acquisitions are a few of the primary tactics used by market participants to obtain a competitive edge. Some of the players concentrate on medical and technology developments that have improved UI management techniques, treatment alternatives, and diagnostic technologies. These developments raised the possibility of favorable results and enhanced the quality of life for those who suffer from the illness.
In January 2022, ICU Medical, Inc. has acquired Smith's Medical, a medical device company. This acquisition will help company to gain a strong position in the global market.
The scope of this report covers the market by its major segments, which include as follows: